Side Chain Sar of Bicyclic Beta-Lactamase Inhibitors (Blis). 1. Discovery of a Class C Bli for Combination with Imipinem.
Blizzard, T.A., Chen, H., Kim, S., Wu, J., Young, K., Park, Y., Ogawa, A., Raghoobar, S., Painter, R.E., Hairston, N., Lee, S.H., Misura, A., Felcetto, T., Fitzgerald, P.M.D., Sharma, N., Lu, J., Ha, S., Hickey, E., Hermes, J., Hammond, M.L.(2010) Bioorg Med Chem Lett 20: 918
- PubMed: 20044254 
- DOI: https://doi.org/10.1016/j.bmcl.2009.12.069
- Primary Citation of Related Structures:  
2WZX, 2WZZ - PubMed Abstract: 
Bridged monobactam beta-lactamase inhibitors were prepared and evaluated as potential partners for combination with imipenem to overcome class C beta-lactamase mediated resistance. The (S)-azepine analog 2 was found to be effective in both in vitro and in vivo assays and was selected for preclinical development.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Labs, Rahway, NJ 07065, USA. tim_blizzard@merck.com